Article

A simple method of sample size calculation for linear and logistic regression

CSPCC, Department of Veterans Affairs, Palo Alto Health Care System (151-K), California 94304, USA.
Statistics in Medicine (Impact Factor: 2.04). 08/1998; 17(14):1623-34. DOI: 10.1002/(SICI)1097-0258(19980730)17:143.0.CO;2-S
Source: PubMed

ABSTRACT A sample size calculation for logistic regression involves complicated formulae. This paper suggests use of sample size formulae for comparing means or for comparing proportions in order to calculate the required sample size for a simple logistic regression model. One can then adjust the required sample size for a multiple logistic regression model by a variance inflation factor. This method requires no assumption of low response probability in the logistic model as in a previous publication. One can similarly calculate the sample size for linear regression models. This paper also compares the accuracy of some existing sample-size software for logistic regression with computer power simulations. An example illustrates the methods.

9 Followers
 · 
1,886 Views
  • Source
    • "Using a significance threshold (alpha-level) of 5% and power of 70%, the required sample size for African ancestry to be associated with the three Dengue outcome severity measures are: 298, 116 and 85 respectively. This is done in the same multivariate regression model that was fitted in Table 6, i.e. includes all the covariates, and assumes the same regression coefficients (Hsieh et al., 1998; Mefford and Witte, 2012). All the analyses were performed using the R statistical software (www.r-project.org) "
    [Show abstract] [Hide abstract]
    ABSTRACT: The wide variation in severity displayed during Dengue Virus (DENV) infection may be influenced by host susceptibility. In several epidemiological approaches, differences in disease outcomes have been found between some ethnic groups, suggesting that human genetic background has an important role in disease severity. In the Caribbean, It has been reported that populations of African descent present considerable less frequency of severe forms compared with Mestizo and White self-reported groups. Admixed populations offer advantages for genetic epidemiology studies due to variation and distribution of alleles, such as those involved in disease susceptibility, as well to provide explanations of individual variability in clinical outcomes. The current study analysed three Colombian populations, which like most of Latin American populations, are made up of the product of complex admixture processes between European, Native American and African ancestors; having as a main goal to assess the effect of genetic ancestry, estimated with 30 Ancestry Informative Markers (AIMs), on DENV infection severity. We found that African Ancestry has a protective effect against severe outcomes under several systems of clinical classification: Severe Dengue (OR: 0.963 for every 1% increase in African Ancestry, 95% confidence interval (0.934 - 0.993), p-value: 0.016), Dengue Haemorrhagic Fever (OR: 0.969, 95% CI (0.947 - 0.991), p-value: 0.006), and occurrence of haemorrhages (OR: 0.971, 95% CI (0.952 - 0.989), p-value: 0.002). Conversely, decrease from 100% to 0% African ancestry significantly increases the chance of severe outcomes: OR is 44-fold for Severe Dengue, 24-fold for Dengue Haemorrhagic Fever, and 20-fold for occurrence of haemorrhages. Furthermore, several warning signs also showed statistically significant association given more evidences in specific stages of DENV infection. These results provide consistent evidence in order to infer statistical models providing a framework for future genetic epidemiology and clinical studies.
    Infection Genetics and Evolution 10/2014; 27. DOI:10.1016/j.meegid.2014.07.003 · 3.26 Impact Factor
  • Source
    • "Exploratory Pearson correlation was used to investigate whether variables might be interrelated . Finally, we considered sample size calculations to allow for multiple rather than only univariate models in future studies concerning additive relationships between various factors associated with increased risk of and severity of LA tears [16] "
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine which maternal characteristics or birth events independently predict severity of levator ani muscle (LA) tears at first vaginal birth in a longitudinal/observational investigation in a tertiary care hospital.
    Open Journal of Obstetrics and Gynecology 04/2014; 4(6):266-278. DOI:10.4236/ojog.2014.46043
  • Source
    • "For the purpose of this study samples were selected based strictly on institutional bases; patients on referral from any other hospital were excluded, to prevent accidental overlap of isolates from the same patients visiting 2 different centres. The sample size was determined using the formula derived by [9] "
    [Show abstract] [Hide abstract]
    ABSTRACT: As a result of the ever increasing problem of multiresistant bacteria, we instituted a surveillance program with the aim of identifying the basic molecular properties of ESBL in our environment. About 197 isolates of Escherichia coli and Klebsiella pneumoniae were selected and tested for ESBL production and antimicrobial susceptibility. Plasmid profiles were determined and curing ability was tested. ESBL prevalence was 26.4% for all isolates tested, with E. coli having a greater proportion. There was absolute resistance to ampicilin, tetracycline, and co-trimaxole among tested isolates. There was above average susceptibility to the 2nd and 3rd generation cephalosporins. Plasmid profiles of tested isolates ranged from 9 kbp to 26 kbp with average of 14.99 ± 2.3 kbp for E. coli and 20.98 ± 1.8 kbp K. pneumoniae, 9.6% of ESBL positive E. coli plasmids were cured, while 3.9% of K. pneumoniae plasmids were cured after treatment. The present study shows an upsurge in ESBL acquisition by gram negative bacteria and evidence of cocirculation of varying subtypes of ESBL with both plasmid transmissible and chromosome encoded subtypes. This calls for universal surveillance and more effort towards molecular epidemiology of this public health treatment.
    Interdisciplinary Perspectives on Infectious Diseases 03/2014; 2014:819896. DOI:10.1155/2014/819896
Show more

Preview

Download
2,761 Downloads
Available from

Questions & Answers about this publication